...at Allergan Inc., where he led worldwide strategy and BD for the company’s medical aesthetics unit.Precirix...
...investment opportunities and creates new ventures. Nowicki identifies new public and private investment opportunities. BC Staff Arcutis Editas Medicine PRECIRIX frazier...

...therapy in preclinical testing for prostate cancer.Belgian radiopharmaceutical company Precirix...

...INKEF Capital , Roche Venture Fund , Novo Seeds , Lundbeckfond Emerge Preclin Neurology 2016 Camel-IDS...

...Camelid-derived antibody company Camel-IDS N.V. (Brussels, Belgium) raised €37 million ($41.7 million) in a series A...
...led the round, which included co-lead investors HealthCap Advisor AB, Novo Seeds, Pontifax and BioMedPartners. Camel-IDS...
...radiolabeled camelid single-domain antibody targeting HER2, can enter brain lesions unlike mAbs. Earlier this year, Camel-IDS...

...Camelid-derived antibody company Camel-IDS N.V. (Brussels, Belgium) raised €37 million ($41.7 million) in a series A...
...led the round, which included co-lead investors HealthCap Advisor AB, Novo Seeds, Pontifax and BioMedPartners. Camel-IDS...
...Morten Graugaard Døssing from Novo Seeds and Ohad Hammer from Pontifax. Camel-IDS N.V., Brussels, Belgium Mark Zipkin CAM-H2 Camel-IDS...

...He was SVP of business development and strategy at Bellicum Pharmaceuticals Inc. (NASDAQ:BLCM). Cancer company Camel-IDS...